agilon health (AGL) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 6, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 2 added, 0 cutMore adding
Federal contractsUSAspending.gov, last 12 months: No awardsNone on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about AGL filings

Are insiders buying or selling agilon health Inc (AGL) stock?

Neither. agilon health Inc (AGL) insiders filed no open-market purchases or sales in the 90 days to Nov 6, 2026, according to SEC Form 4 filings.

Which members of Congress have traded AGL recently?

None. No member of Congress disclosed a AGL trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this AGL smart-money data?

This summary uses filings available on Nov 6, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on AGL

Lean long1 source:
- Funds

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Politicians
No recent politician filings found
Funds
- Marshall Wace, added, holdings at Jun 30
- Durable Capital, added, holdings at Jun 30
Lean long · thin2 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about AGL filings

Are insiders buying or selling agilon health Inc (AGL) stock?

Neither. agilon health Inc (AGL) insiders filed no open-market purchases or sales in the 90 days to Nov 6, 2026, according to SEC Form 4 filings.

Which members of Congress have traded AGL recently?

None. No member of Congress disclosed a AGL trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this AGL smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$97.4M

Buys/Adds (2)

DC
Durable Capital
Henry Ellenbogen · Q2 2026 13F
$47.2M
bought
Signals like this: n=3225, 54% finished lower at D15, median -0.8% vs SPY -0.4%
MW
Marshall Wace
Q2 2026 13F
$50.2M
bought

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 4, 2026

Earnings came in $2.81 a share above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 4, 2026

Period ending

Sep 30, 2026

Earnings per share

$2.08+$2.81 beat

-$0.73 expected

Revenue

$1.52B

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 4, 2026	$2.08est. -$0.73	+$2.81beat	$1.52BSEC filing	+5.9%from $1.44B
Jun 30, 2026Reported Aug 5, 2026	$2.15est. $0.27	+$1.88beat	$1.49BSEC filing	+7.2%from $1.39B
Mar 31, 2026Reported May 6, 2026	$2.32est. $0.93	+150.00%beat	$1.42BSEC filing	-7.3%from $1.53B
Dec 31, 2025Reported Feb 25, 2026	-$8.95est. -$6.85	-30.66%miss	$1.57BYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 4, 2025	-$6.75est. -$4.11	-64.23%miss	$1.44BSEC filing	-1.1%from $1.45B
Jun 30, 2025Reported Aug 4, 2025	-$6.30est. -$2.66	-136.84%miss	$1.39BSEC filing	-5.9%from $1.48B
Mar 31, 2025Reported May 6, 2025	$0.75est. -$0.29	+$1.04beat	$1.53BSEC filing	-4.5%from $1.60B
Dec 31, 2024Reported Feb 25, 2025	-$0.25est. -$0.13	-95.31%miss	$6.06B · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $91.17
52-wk high: $133.04
High: $98.02
52-wk low: $7.48
Low: $90.23
Prev close: $87.79
Mkt cap: $1.62B
ROE: -78.9%
Fwd P/E: 178.6x
Beta: 3.11
P/S: 0.3x
P/B: 6.5x
Profit margin: -3.9%
Op margin: +1.3%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -3.9%
Forward P/E: 178.57
Market cap: $1.6B

Valuation

P/S0.27
P/B6.48

Quality

Operating margin1.3%
ROE-78.9%
ROA-9.6%

Growth

Beta3.11

Technicals

Price structure

This stock is in a strong uptrend.

Trend

Strong uptrend

100 / 100

RSI 14

63balanced

20D volatility

50%annualized

52-week range

$96.23

$7.48$133.04

20D support

$81.16recent floor

20D resistance

$98.02recent ceiling

Returns

5D +5.7%20D +12.3%60D +11.4%

Price vs moving averages

SMA20 +9.1%SMA50 +9.9%SMA200 +45.9%

Volume pace

0.79xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 4, 2026

$2.08est. -$0.73

+$2.81

$1.52BSEC filing

+5.9%from $1.44B

Jun 30, 2026Aug 5, 2026

$2.15est. $0.27

+$1.88

$1.49BSEC filing

+7.2%from $1.39B

Mar 31, 2026May 6, 2026

$2.32est. $0.93

+150.00%

$1.42BSEC filing

-7.3%from $1.53B

Dec 31, 2025Feb 25, 2026

-$8.95est. -$6.85

-30.66%

$1.57BYahoo Finance

No year-ago quarter

Sep 30, 2025Nov 4, 2025

-$6.75est. -$4.11

-64.23%

$1.44BSEC filing

-1.1%from $1.45B

Jun 30, 2025Aug 4, 2025

-$6.30est. -$2.66

-136.84%

$1.39BSEC filing

-5.9%from $1.48B

Mar 31, 2025May 6, 2025

$0.75est. -$0.29

+$1.04

$1.53BSEC filing

-4.5%from $1.60B

Dec 31, 2024Feb 25, 2025

-$0.25est. -$0.13

-95.31%

$6.06B · FYSEC filing

No year-ago quarter

agilon health Inc

Smart money at a glance

What do analysts expect?

Questions about AGL filings

Smart money on AGL

Questions about AGL filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in $2.81 a share above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

agilon health Inc

Smart money at a glance

What do analysts expect?

Questions about AGL filings

Smart money on AGL

Questions about AGL filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in $2.81 a share above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

agilon health Inc

Overview

Questions about AGL filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

agilon health Inc

Overview

Questions about AGL filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.